Unknown

Dataset Information

0

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation.

ABSTRACT: Supplemental Digital Content is available in the text.

SUBMITTER: Jentzsch M 

PROVIDER: S-EPMC7000468 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Outcomes of Older Patients with <i>NPM1</i> Mutated and <i>FLT3</i>-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation.

Jentzsch Madlen M   Grimm Juliane J   Bill Marius M   Goldmann Karoline K   Schulz Julia J   Niederwieser Dietger D   Platzbecker Uwe U   Schwind Sebastian S  

HemaSphere 20200103 1

Similar Datasets

Unknown Maintenance therapy for <i>FLT3-ITD</i>-mutated acute myeloid leukemia.
| S-EPMC7927878 | biostudies-literature
Unknown Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells.
| S-EPMC7150460 | biostudies-literature
Unknown Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.
| S-EPMC4544001 | biostudies-literature
Unknown Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type <i>NPM1</i> without <i>FLT3</i>-ITD.
| S-EPMC6779939 | biostudies-literature
Unknown <i>NPM1</i> and <i>FLT3-ITD/TKD</i> Gene Mutations in Acute Myeloid Leukemia.
| S-EPMC7885130 | biostudies-literature
Unknown Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.
| S-EPMC6201699 | biostudies-literature
Unknown ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia.
| S-EPMC7212592 | biostudies-literature
Unknown CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia.
| S-EPMC8149417 | biostudies-literature
Unknown Treatment of FLT3-ITD acute myeloid leukemia.
| S-EPMC3301423 | biostudies-literature
Unknown Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden.
| S-EPMC7796342 | biostudies-literature